Publicacions en què col·labora amb Zoraida Verde Rello (18)

2017

  1. Exercise Intervention in Pediatric Patients with Solid Tumors: The Physical Activity in Pediatric Cancer Trial

    Medicine and Science in Sports and Exercise, Vol. 49, Núm. 2, pp. 223-230

  2. Telomere length in elite athletes

    International Journal of Sports Physiology and Performance, Vol. 12, Núm. 7, pp. 994-996

2015

  1. Exceptional longevity and muscle and fitness related genotypes: A functional in vitro analysis and case-control association replication study with SNPs THRH rs7832552, IL6 rs1800795 and ACSL1 rs6552828

    Frontiers in Aging Neuroscience, Vol. 7, Núm. APR

  2. Physical-capacity-related genetic polymorphisms in children with cystic fibrosis

    Pediatric Exercise Science, Vol. 27, Núm. 1, pp. 102-112

2014

  1. ACTN3 R577X polymorphism and explosive leg-muscle power in elite basketball players

    International Journal of Sports Physiology and Performance, Vol. 9, Núm. 2, pp. 226-232

  2. ApoE gene and exceptional longevity: Insights from three independent cohorts

    Experimental Gerontology, Vol. 53, pp. 16-23

  3. Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6 ?

    Pharmacopsychiatry, Vol. 47, Núm. 1, pp. 33-36

2012

  1. Acyl coenzyme A synthetase long-chain 1 (ACSL1) gene polymorphism (rs6552828) and elite endurance athletic status: A replication study

    PLoS ONE, Vol. 7, Núm. 7

2011

  1. 'Smoking Genes': A genetic association study

    PLoS ONE, Vol. 6, Núm. 10

  2. ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players

    Scandinavian Journal of Medicine and Science in Sports, Vol. 21, Núm. 6

2010

  1. A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants

    PLoS ONE, Vol. 5, Núm. 6

  2. ACE and ACTN3 genes and muscle phenotypes in nonagenarians

    International Journal of Sports Medicine, Vol. 31, Núm. 4, pp. 221-224

  3. Are elite endurance athletes genetically predisposed to lower disease risk?

    Physiological Genomics, Vol. 41, Núm. 1, pp. 82-90

  4. Is there an association between ACTN3 R577X polymorphism and muscle power phenotypes in young, non-athletic adults?

    Scandinavian Journal of Medicine and Science in Sports, Vol. 20, Núm. 5, pp. 771-778

2009

  1. Genotype distributions in top-level soccer players: A role for ace ?

    International Journal of Sports Medicine, Vol. 30, Núm. 5, pp. 387-392

  2. Is there an optimum endurance polygenic profile?

    Journal of Physiology, Vol. 587, Núm. 7, pp. 1527-1534

  3. Pharmacogenetics of acenocoumarol: CYP2C9 *2 and VKORCI c.-l 639G>A, 497C>G, 1173C>T, and 3730G>A variants influence drug dose in anticoagulated patients

    Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 591-593

  4. Unique among unique. Is it genetically determined?

    British Journal of Sports Medicine, Vol. 43, Núm. 4, pp. 307-309